Celsius (NASDAQ:CELH) Raised to Buy at TD Cowen

TD Cowen upgraded shares of Celsius (NASDAQ:CELH) from a hold rating to a buy rating in a research note published on Monday morning, MarketBeat Ratings reports. TD Cowen currently has $55.00 price objective on the stock, up from their prior price objective of $37.00.

CELH has been the topic of several other reports. LADENBURG THALM/SH SH decreased their price target on shares of Celsius from $62.00 to $58.00 and set a “neutral” rating on the stock in a research note on Thursday, March 27th. Truist Financial raised their target price on shares of Celsius from $45.00 to $50.00 and gave the stock a “buy” rating in a research report on Friday, June 6th. JPMorgan Chase & Co. lifted their target price on shares of Celsius from $39.00 to $44.00 and gave the stock an “overweight” rating in a research note on Friday, May 2nd. Needham & Company LLC reissued a “buy” rating and set a $47.00 price target on shares of Celsius in a research note on Thursday, May 29th. Finally, Stifel Nicolaus initiated coverage on Celsius in a research report on Thursday, June 12th. They issued a “buy” rating and a $47.00 price objective for the company. One research analyst has rated the stock with a sell rating, three have given a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, Celsius presently has an average rating of “Moderate Buy” and an average price target of $47.24.

Celsius Stock Performance

CELH stock opened at $44.07 on Monday. The stock’s 50 day moving average price is $37.78 and its 200 day moving average price is $31.53. The firm has a market cap of $11.36 billion, a P/E ratio of 137.72, a PEG ratio of 1.59 and a beta of 1.43. Celsius has a 1 year low of $21.10 and a 1 year high of $64.19.

Celsius (NASDAQ:CELH) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by ($0.02). The company had revenue of $329.28 million during the quarter, compared to analysts’ expectations of $349.09 million. Celsius had a net margin of 8.40% and a return on equity of 42.12%. The firm’s revenue was down 7.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.27 earnings per share. On average, research analysts predict that Celsius will post 0.89 earnings per share for the current year.

Insider Transactions at Celsius

In other news, CEO John Fieldly sold 132,171 shares of the business’s stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $43.06, for a total transaction of $5,691,283.26. Following the completion of the sale, the chief executive officer now owns 1,169,380 shares in the company, valued at approximately $50,353,502.80. The trade was a 10.15% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 2.55% of the company’s stock.

Institutional Trading of Celsius

A number of institutional investors and hedge funds have recently bought and sold shares of CELH. HM Payson & Co. grew its stake in Celsius by 122.2% during the fourth quarter. HM Payson & Co. now owns 1,000 shares of the company’s stock worth $26,000 after buying an additional 550 shares during the period. Westside Investment Management Inc. purchased a new stake in Celsius during the 1st quarter worth $32,000. Summit Securities Group LLC acquired a new stake in Celsius in the 1st quarter valued at $34,000. MassMutual Private Wealth & Trust FSB raised its position in Celsius by 255.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company’s stock valued at $37,000 after purchasing an additional 750 shares during the period. Finally, Knuff & Co LLC purchased a new position in Celsius in the fourth quarter valued at about $50,000. Institutional investors and hedge funds own 60.95% of the company’s stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.